The initial form, now termed CM-AVM type 1 (CM-AVM1), was first described in 2003 and is due to heterozygous loss-of-function mutations in RASA1, which encodes p120-RasGAP. Here, RASA1 is linked to capillary malformation-arteriovenous malformation 1.